A phase I study of pazopanib in combination with escalating doses of 131I in patients with well-differentiated thyroid carcinoma borderline refractory to radioiodine-Reference-Cited by-同舟云学术

A phase I study of pazopanib in combination with escalating doses of 131I in patients with well-differentiated thyroid carcinoma borderline refractory to radioiodine

Published:2017-06-29 Issue:6 Volume:12 Page:e0178325
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Chow Laura Q.,Santana-Davila Rafael^ORCID,Pantel Austin,Roth Mara,Anderson Leslie N.,Failor Alan,Doot Robert,Mankoff David

Funder

National Comprehensive Cancer Network (NCCN)

Novartis Pharmaceuticals Corporation (US)

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference21 articles.

1. Increasing incidence of thyroid cancer in the United States, 1973–2002;L Davies;JAMA,2006

2. Current thyroid cancer trends in the United States;L Davies;JAMA Otolaryngol Head Neck Surg,2014

3. Cancer statistics, 2015;RL Siegel;CA Cancer J Clin,2015

4. Differentiated thyroid cancer;WR Burns;Semin Oncol,2010

5. Nuclear medicine in the assessment of differentiated thyroid cancer;GC Rutherford;Clin Radiol,2008

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leveraging molecular targeted drugs and immune checkpoint inhibitors treat advanced thyroid carcinoma to achieve thyroid carcinoma redifferentiation;American Journal of Cancer Research;2024

2. Radioiodine therapy in advanced differentiated thyroid cancer: Resistance and overcoming strategy;Drug Resistance Updates;2023-05

3. Radioiodine Refractory Thyroid Cancer;Practical Management of Thyroid Cancer;2023

4. In Silico Screening and Validation of PDGFRA Inhibitors Enhancing Radioiodine Sensitivity in Thyroid Cancer;Frontiers in Pharmacology;2022-05-12

5. State of the Art in the Current Management and Future Directions of Targeted Therapy for Differentiated Thyroid Cancer;International Journal of Molecular Sciences;2022-03-23